SICKLE B+ THALASSEMIA
Clinical trials for SICKLE B+ THALASSEMIA explained in plain language.
Never miss a new study
Get alerted when new SICKLE B+ THALASSEMIA trials appear
Sign up with your email to follow new studies for SICKLE B+ THALASSEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
A Pocket-Sized coach for sickle cell: can an app turn Pill-Taking into a habit?
Disease control CompletedThis study follows adolescents and young adults (ages 12–21) with sickle cell disease who take hydroxyurea, a medication that helps prevent pain crises and other complications. The researchers are testing whether a mobile app called HU-Go can help these patients build a consisten…
Matched conditions: SICKLE B+ THALASSEMIA
Phase: NA • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a phone app keep teens on track with sickle cell treatment?
Disease control CompletedThis pilot trial tests whether a smartphone app called MED-Go can help adolescents and young adults with sickle cell disease take their daily hydroxyurea more consistently. Participants aged 12 to 21 will use the app for 12 weeks, and researchers will measure how often they log t…
Matched conditions: SICKLE B+ THALASSEMIA
Phase: NA • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC